Cargando…

Associations among stressors across the lifespan, disability, and relapses in adults with multiple sclerosis

INTRODUCTION: Stress and adversity during childhood, adolescence, and adulthood could impact the present and future health and well‐being of people with multiple sclerosis (PwMS); however, a lifespan approach and nuanced stressor data are scarce in this nascent area of research. Our aim was to exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polick, Carri S., Ploutz‐Snyder, Robert, Braley, Tiffany J., Connell, Cathleen M., Stoddard, Sarah A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338783/ https://www.ncbi.nlm.nih.gov/pubmed/37211908 http://dx.doi.org/10.1002/brb3.3073

Ejemplares similares

Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress
por: Polick, Carri S., et al.
Publicado: (2023)

Immigration‐related stressors and health outcomes among low‐wage immigrant hotel workers: A pilot study
por: Rosemberg, Marie‐Anne S., et al.
Publicado: (2022)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Sex effects across the lifespan in women with multiple sclerosis
por: Krysko, Kristen M., et al.
Publicado: (2020)

Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
por: Khatibi, Ali, et al.
Publicado: (2020)

Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine
por: Fyfe, Ian
Publicado: (2021)

The role of disconnection in explaining disability in multiple sclerosis
por: Lapucci, Caterina, et al.
Publicado: (2022)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective
por: Meca-Lallana, José, et al.
Publicado: (2020)

Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
por: Sainz de la Maza, Susana, et al.
Publicado: (2023)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

The Impact of Pet Care Needs on Medical Decision-Making among Hospitalized Patients: A Cross-Sectional Analysis of Patient Experience
por: Polick, Carri S., et al.
Publicado: (2021)

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2020)

AGING-RELATED CHANGES IN DAILY STRESSOR CONTROL AND GENERAL PERCEIVED CONTROL ACROSS THE LIFESPAN
por: Cerino, Eric, et al.
Publicado: (2022)

White matter lesion location correlates with disability in relapsing multiple sclerosis
por: Gaetano, Laura, et al.
Publicado: (2020)

Effect of Combined Stressors on C. elegans Lifespan
por: Hull, Bradford, et al.
Publicado: (2021)

Fatigue, Tiredness, Lack of Energy, and Sleepiness in Multiple Sclerosis Patients Referred for Clinical Polysomnography
por: Braley, Tiffany J., et al.
Publicado: (2012)

Sedentary Behavior and Lower-Extremity Physical Function across the Lifespan of Adults with Multiple Sclerosis
por: Jeng, Brenda, et al.
Publicado: (2022)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability
por: Sotiropoulos, Marinos G, et al.
Publicado: (2021)

Direct and indirect effects of age on interoceptive accuracy and awareness across the adult lifespan
por: Murphy, Jennifer, et al.
Publicado: (2017)

LIFESPAN NEURODEGENERATION OF THE HUMAN BRAIN IN MULTIPLE SCLEROSIS
por: Coupé, Pierrick, et al.
Publicado: (2023)

Lifespan neurodegeneration of the human brain in multiple sclerosis
por: Coupé, Pierrick, et al.
Publicado: (2023)

Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing–Remitting Multiple Sclerosis
por: Kieseier, Bernd C., et al.
Publicado: (2014)

Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis
por: Cadavid, Diego, et al.
Publicado: (2013)

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
por: Migliore, S., et al.
Publicado: (2017)

Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2020)

Hypertension Among US Adults by Disability Status and Type, National Health and Nutrition Examination Survey, 2001–2010
por: Stevens, Alissa, et al.
Publicado: (2014)

Effects of Cohort Selection on the Results of Cost-Effectiveness Analysis of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis
por: Becker III, Russell V., et al.
Publicado: (2011)

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients
por: Jamroz-Wiśniewska, Anna, et al.
Publicado: (2021)

What Do We Know So Far about Ofatumumab for Relapsing Multiple Sclerosis? A Meta-Analytical Study
por: Taj, Hafiza Munazza, et al.
Publicado: (2022)

Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
por: Lavery, Amy M., et al.
Publicado: (2014)

The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis
por: Hadgkiss, Emily J, et al.
Publicado: (2015)

Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis
por: Zhou, Fuqing, et al.
Publicado: (2016)

Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability
por: Siotto, Mariacristina, et al.
Publicado: (2019)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
por: Has Silemek, Arzu Ceylan, et al.
Publicado: (2020)

Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
por: Kapica-Topczewska, Katarzyna, et al.
Publicado: (2021)

Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2021)

Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kricl4jhbp3riar1m8up3l30f0